2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study.
暂无分享,去创建一个
H. Hellmold | K. Nilsson | H. Håkansson | Nick Fletcher | David Wahlström | Rebecca Lundberg | Charlotte B Nilsson | Kerstin C Nilsson | Kenneth Stockling | Heike Hellmold | Helen Håkansson | N. Fletcher | Kenneth Stockling | D. Wahlström | C. Nilsson | R. Lundberg
[1] K. Chung,et al. Protective effects of ursodeoxycholic acid against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced testicular damage in mice. , 2004, Toxicology and applied pharmacology.
[2] Giovanni Galli,et al. Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.
[3] M. Ananthanarayanan,et al. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M200489-JLR200 , 2003, Journal of Lipid Research.
[4] K. Geering,et al. FXYD Proteins: New Tissue‐ and Isoform‐Specific Regulators of Na,K‐ATPase , 2003, Annals of the New York Academy of Sciences.
[5] H. Nau,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the endogenous metabolism of all-trans-retinoic acid in the rat , 2003, Archives of Toxicology.
[6] H. Rho,et al. The trascriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the anitoxidant responsive element and xenobiotic responsive element , 2002, Molecular and Cellular Biochemistry.
[7] F. Gonzalez,et al. The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)* , 2002, The Journal of Biological Chemistry.
[8] A. Fornace,et al. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a , 2002, Oncogene.
[9] W. Bosron,et al. Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. , 2002, European journal of biochemistry.
[10] K. Geering,et al. Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Rice,et al. Gene-specific TCDD suppression of RARalpha- and RXR-mediated induction of tissue transglutaminase. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[12] Celeste Eng,et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. , 2002, The Journal of clinical investigation.
[13] C. Tohyama,et al. Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive genes in mouse liver by serial analysis of gene expression. , 2002, Biochemical and biophysical research communications.
[14] H. Håkansson,et al. The Retinoid Signaling System — A Target in Dioxin Toxicity , 2002, Critical reviews in toxicology.
[15] P. Brown,et al. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. , 2001, Toxicology letters.
[16] M. Makishima,et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.
[17] C. Klinge,et al. Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT). , 2001, Archives of biochemistry and biophysics.
[18] Xianshu Wang,et al. Analysis of mouse retinal dehydrogenase type 2 promoter and expression. , 2001, Genomics.
[19] F. Matschinsky,et al. Effect of retinoic acid on glucokinase activity and gene expression in neonatal and adult cultured hepatocytes. , 2001, Life sciences.
[20] H. Yamada,et al. Effects of a highly toxic coplanar polychlorinated biphenyl, 3,3',4,4',5-pentachlorobiphenyl on intermediary metabolism: reduced triose phosphate content in rat liver cytosol. , 2001, Fukuoka igaku zasshi = Hukuoka acta medica.
[21] E. Harrison,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum and kidney retinoic acid levels and kidney retinol esterification in the rat. , 2000, Toxicology and applied pharmacology.
[22] J. Chou,et al. Structural Requirements for the Stability and Microsomal Transport Activity of the Human Glucose 6-Phosphate Transporter* , 2000, The Journal of Biological Chemistry.
[23] M. Medvedovic,et al. The transcriptional signature of dioxin in human hepatoma HepG2 cells. , 2000, Biochemical pharmacology.
[24] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[25] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[26] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[27] M. Green,et al. Mobilization of vitamin A stores in rats after administration of 2,3, 7,8-tetrachlorodibenzo-p-dioxin: a kinetic analysis. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[28] E. Harrison,et al. Lipases and carboxylesterases: possible roles in the hepatic utilization of vitamin A. , 2000, The Journal of nutrition.
[29] P. Meier,et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.
[30] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[31] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[32] X. Wang,et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 , 1999, Oncogene.
[33] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[34] C. Harris,et al. GADD45 induction of a G2/M cell cycle checkpoint. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] H. Yawo,et al. Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2) , 1999, FEBS letters.
[36] Y. Li,et al. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1999, Toxicology and applied pharmacology.
[37] J. Thomsen,et al. The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ERα and ERβ* , 1999, The Journal of Biological Chemistry.
[38] B. Annabi,et al. Cloning and Characterization of cDNAs Encoding a Candidate Glycogen Storage Disease Type 1b Protein in Rodents* , 1998, The Journal of Biological Chemistry.
[39] D. Moore,et al. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). , 1998, Molecular endocrinology.
[40] D. Tew,et al. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. , 1998, The Biochemical journal.
[41] R. Edwards,et al. Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia. , 1998, Biochemical pharmacology.
[42] M. Green,et al. Use of model-based compartmental analysis to study effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A kinetics in rats. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[43] B. Annabi,et al. Transmembrane Topology of Glucose-6-Phosphatase* , 1998, The Journal of Biological Chemistry.
[44] G. Lucier,et al. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria. , 1998, Carcinogenesis.
[45] C. Jefcoate,et al. Characterization of the Mouse Cyp1B1 Gene , 1998, The Journal of Biological Chemistry.
[46] K. Bock,et al. Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. , 1998, Archives of biochemistry and biophysics.
[47] I. Gérin,et al. Sequence of a putative glucose 6‐phosphate translocase, mutated in glycogen storage disease type Ib 1 , 1997, FEBS letters.
[48] P. Meier,et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.
[49] E. Harrison,et al. Purification and Characterization of a Neutral, Bile Salt-independent Retinyl Ester Hydrolase from Rat Liver Microsomes , 1997, The Journal of Biological Chemistry.
[50] P. Meier,et al. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] H. Yamada,et al. Species-specific alteration of hepatic glucose 6-phosphate dehydrogenase activity with coplanar polychlorinated biphenyl: evidence for an Ah-receptor-linked mechanism. , 1997, Chemosphere.
[52] T. Visser,et al. Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats. , 1997, Endocrinology.
[53] J. Girard,et al. Effects of triiodothyronine and retinoic acid on glucokinase gene expression in neonatal rat hepatocytes , 1997, Molecular and Cellular Endocrinology.
[54] L. Birnbaum,et al. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats. , 1997, Biochemical and biophysical research communications.
[55] J. McGarry,et al. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.
[56] T. Tsukamoto,et al. An orphan nuclear receptor lacking a zinc-finger DNA-binding domain: interaction with several nuclear receptors. , 1997, Biochimica et biophysica acta.
[57] P. O'Connor,et al. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation. , 1996, DNA and cell biology.
[58] A. Hanberg,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects retinol esterification in rat hepatic stellate cells and kidney. , 1996, Environmental toxicology and pharmacology.
[59] S. Okino,et al. Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] D. Moore,et al. An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.
[61] N. Sanz,et al. Changes in glucose-6-phosphate dehydrogenase and malic enzyme gene expression in acute hepatic injury induced by thioacetamide. , 1996, Biochemical pharmacology.
[62] T. Iyanagi,et al. Xenobiotic Responsive Element-mediated Transcriptional Activation in the UDP-glucuronosyltransferase Family 1 Gene Complex (*) , 1996, The Journal of Biological Chemistry.
[63] B. Stahl,et al. Tissue-specific effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats. , 1995, Toxicology and applied pharmacology.
[64] R. Ulrich,et al. Upregulation of glucose-6-phosphate dehydrogenase in response to hepatocellular oxidative stress: studies with diquat. , 1995, Journal of biochemical toxicology.
[65] B. Stahl,et al. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice. , 1995, Toxicology and applied pharmacology.
[66] R. Pohjanvirta,et al. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. , 1994, Pharmacological reviews.
[67] K. Takimoto,et al. Structure of the 5' flanking region of class 3 aldehyde dehydrogenase in the rat. , 1994, Archives of biochemistry and biophysics.
[68] U. Hellman,et al. Molecular cloning and identification of a rat serum carboxylesterase expressed in the liver. , 1994, The Journal of biological chemistry.
[69] R. Tukey,et al. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. , 1994, The Journal of biological chemistry.
[70] R. Kletzien,et al. Glucose‐6‐phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue‐specific regulation by hormones, nutrients, and oxidant stress , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] N. Casals,et al. Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. , 1993, Archives of biochemistry and biophysics.
[72] B. Stahl,et al. Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels. , 1993, Toxicology.
[73] D. Russell,et al. Bile acid biosynthesis. , 1992, Biochemistry.
[74] H. W. Schaup,et al. Alterations of hepatic acetyl-CoA carboxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1991, Lipids.
[75] K. Dakshinamurti,et al. Transcriptional regulation of the glucokinase gene by biotin in starved rats. , 1991, The Journal of biological chemistry.
[76] S. Chirtel,et al. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.
[77] C. B. Pickett,et al. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. , 1991, The Journal of biological chemistry.
[78] B. Stahl,et al. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. , 1991, Toxicology.
[79] O. Griffith,et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reliance on fats as a fuel source independently of diet: evidence that diminished carbohydrate supply contributes to dioxin lethality. , 1991, Biochemical and biophysical research communications.
[80] P. Ferré,et al. Insulin and tri-iodothyronine induce glucokinase mRNA in primary cultures of neonatal rat hepatocytes. , 1990, The Biochemical journal.
[81] C. Slaughter,et al. Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. , 1990, The Journal of biological chemistry.
[82] J. Darnell,et al. Analysis of the upstream elements of the xenobiotic compound-inducible and positionally regulated glutathione S-transferase Ya gene , 1990, Molecular and cellular biology.
[83] T. Rushmore,et al. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[84] C. Southan,et al. Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. , 1990, The Journal of biological chemistry.
[85] T. Nouspikel,et al. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. , 1989, The Journal of biological chemistry.
[86] M. Zile,et al. Effect of tetrachlorodibenzo-p-dioxin (TCDD) on the glucuronidation of retinoic acid in the rat. , 1989, Biochimica et biophysica acta.
[87] J. Whitlock,et al. Protein-DNA interactions at recognition sites for the dioxin-Ah receptor complex. , 1989, The Journal of biological chemistry.
[88] J. Fargnoli,et al. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents , 1989, Molecular and cellular biology.
[89] G. Muzi,et al. Mode of metabolism is altered in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. , 1989, Toxicology letters.
[90] J. Whitlock,et al. The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. , 1988, The Journal of biological chemistry.
[91] S. Chirtel,et al. Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat , 1988, Lipids.
[92] J. Mathis,et al. Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. , 1988, Carcinogenesis.
[93] L. Birnbaum,et al. The acute toxicity of 2,3,4,7,8-pentachlorodibenzofuran (4PeCDF) in the male Fischer rat , 1988 .
[94] L. Birnbaum,et al. Toxicity and disposition of 2,3,4,7,8-pentachlorodibenzofuran (4PeCDF) in the rhesus monkey (Macaca mulatta). , 1988, Toxicology and applied pharmacology.
[95] L. Birnbaum,et al. Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin (OCDD) during a 13-week study. , 1988, Toxicology and applied pharmacology.
[96] Y. Fujii‐Kuriyama,et al. Characterization of xenobiotic responsive elements upstream from the drug-metabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. , 1987, Nucleic acids research.
[97] R. Peterson,et al. Hepatic indices of thyroid status in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1987, Biochemical pharmacology.
[98] R. Peterson,et al. Intermediary metabolism of the mature rat following 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. , 1986, Toxicology and applied pharmacology.
[99] R. Peterson,et al. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[100] D. Stumpo,et al. The effect of ethanol, alone and in combination with the glucocorticoids and insulin, on glucose-6-phosphate dehydrogenase synthesis and mRNA in primary cultures of hepatocytes. , 1985, The Biochemical journal.
[101] F. Matsumura,et al. Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD) , 1984, Archives of environmental contamination and toxicology.
[102] R. Peterson,et al. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1984, Toxicology and applied pharmacology.
[103] I. Sipes,et al. Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration. , 1983, Toxicology and applied pharmacology.
[104] B. Yoo,et al. Effects of halogenated dibenzo-p-dioxins on plasma disappearance and biliary excretion of ouabain in rats. , 1983, Toxicology letters.
[105] R. Peterson,et al. Depression of adenosine triphosphatase activities in isolated liver surface membranes of 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats: correlation with effects on ouabain biliary excretion and bile flow. , 1979, The Journal of pharmacology and experimental therapeutics.
[106] R. Peterson,et al. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on plasma disappearance and biliary excretion of foreign compounds in rats. , 1977, Toxicology and applied pharmacology.
[107] J. G. Hamilton,et al. Effect of (−)-hydroxycitrate upon the accumulation of lipid in the rat: I. Lipogenesis , 1974, Lipids.
[108] J. Goldstein,et al. Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse. , 1973, Research communications in chemical pathology and pharmacology.
[109] J. S. Woods. Studies of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on mammalian hepatic delta-aminolevulinic acid synthetase. , 1973, Environmental health perspectives.
[110] P. Veldhoven,et al. Peroxisomal lipid degradation via β-and α-oxidation in Mammals , 2007, Cell Biochemistry and Biophysics.
[111] H. Greim,et al. Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats , 2005, Archives of Toxicology.
[112] Y. Kan,et al. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduc , 2004, The Biochemical journal.
[113] L Nagy,et al. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. , 2003, Journal of biological regulators and homeostatic agents.
[114] Magnus Åstrand,et al. Contrast Normalization of Oligonucleotide Arrays , 2003, J. Comput. Biol..
[115] S. Choudhuri,et al. Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. , 2002, The Journal of pharmacology and experimental therapeutics.
[116] P. Meier,et al. Hepatic Transport of Bile Salts , 2000, Seminars in liver disease.
[117] A. Fornace,et al. Role of Gadd45 in apoptosis. , 2000, Biochemical pharmacology.
[118] J. Tuomisto,et al. ORGAN TOXICITY AND MECHANISMS , 1999 .
[119] J. Whitlock,et al. Induction of cytochrome P4501A1. , 1999, Annual review of pharmacology and toxicology.
[120] H. Ashida,et al. Effect of in vivo administered 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin on DNA‐binding activities of nuclear transcription factors in liver of guinea pigs , 1998, Journal of biochemical and molecular toxicology.
[121] C. Bradfield,et al. Ah receptor signaling pathways. , 1996, Annual review of cell and developmental biology.
[122] G. Clark,et al. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. , 1994, Cancer research.
[123] S. Chirtel,et al. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat. , 1989, The Journal of pharmacology and experimental therapeutics.
[124] R. Melnick,et al. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in F344 rats by di(2-ethylhexyl)phthalate. , 1988, Chemico-biological interactions.
[125] S. Aust,et al. Activity of thyroid hormone-inducible enzymes following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1988, Toxicology and applied pharmacology.
[126] R. Peterson,et al. Relationship of alterations in energy metabolism to hypophagia in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1986 .
[127] A Poland,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.
[128] Y. Muto,et al. Synthesis and degradation of the lipogenic enzymes of rat liver. , 1972, Advances in enzyme regulation.